Synthesis and immunosuppressive activity of lipophilic amino alcohols and diamines

Chemical Biology and Drug Design

Volumn 72, Issue 6, 2008, Pages 596-598

  Reis, Elaine F C ^a   Júnior, Celso O R ^a   Alves, Lívia L ^a   Ferreira, Ana Paula ^a   De Almeida, Mauro V ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Amino alcohols; Delayed type hypersensitivity; Diamines; Immunosuppressive activity

Indexed keywords

AMINOALCOHOL; DIAMINE; IMMUNOSUPPRESSIVE AGENT; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ALCOHOLS; ANIMALS; CELLS, CULTURED; DIAMINES; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; MICE;

EID: 56649120225     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00740.x     Document Type: Article

References (16)

1. Allison A.C. (2000) Immunossupressive drugs: the first 50 years and glance forward. Immunopharm 47 : 63 83.
2. Janeway C.A.J. Medzhitov R., (2002) Innate immune recognition. Annu Rev Immunol 20 : 197 216.
3. Rocha P.N., Plumb T.J., Crowley S.D., Coffman T.M. (2003) Effector mechanisms im transplant rejection. Immunol Rev 196 : 51 64.
4. Barton G.M. (2008) A calculated response: control of inflammation by the innate immune system. J Clin Invest 118 : 413 420.
5. Guimarães V.C., Quintans J., Fisfalen M-E, Fields P.E., Medeiros-Neto G., Degroot L.G. (1996) Immunossupression of Thyroiditis. Endocrinology 137 : 2199 2207.
6. Curvello Neto A.L., Costa M.C., Burdmann E.C., Yu L. (2000) Atualização em insuficiência renal aguda: Nefrotoxicidade aguda de drogas imunossupressoras. J Bras Nefrol 22 : 114 120.
7. Hallorran P.F. (2004) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351 : 2715 2729.
8. Brinkmann V. (2004) FTY720: Mechanism of action and potential benefit in organ transplantation. Yonsei Med J 45 : 991 997.
9. Kotti S.R.S.S., Timmons C., Li G. (2006) Vicinal diamino functionalities as privileged structural elements in biologically active compounds and exploitation of their synthetic chemistry. Chem Biol Drug Des 67 : 101 114.
10. Giordani R.B., De Almeida M.V., Fernandes E., Costa C.F., Carli G.A.D., Tasca T., Zuanazzi J.A. (2008) Anti-Trichomonas vaginalis activity of synthetic lipophilic butanediamine and amino alcohol derivatives Biomed. Pharmacotherapy. in press. doi :.
11. Costa C.F., Coimbra E.S., Braga F.G., Reis R.C.N., Silva A.D., De Almeida M.V. (2008) Preparation and antileishmanial activity of lipophilic N-alkyl diamines. Biomed Pharmacother. in press. doi :.
12. Taveira A.F., Le Hyaric M., Reis E.F.C., Araújo D.P., Ferreira A.P., Souza M.A., Alves L.L., Lourenço M.C.S., Vicente F.R.C., Almeida M.V. (2007) Preparation and antitubercular activities of alkylated amino alcohols and their glycosylated derivatives. Bioorg Med Chem 15 : 7789 7794.
13. del Olmo E., Plaza A., Muro A., Martínez-Fernández A.R., Nogal-Ruiz J.J., López-Pérez J.L., Feliciano A.S. (2006) Synthesis and evaluation of some lipidic aminoalcohols and diamines as immunomodulators. Bioorg Med Chem Lett 8 : 113 118.
14. Yoshikawa M., Yokokawa Y., Okuno Y., Murakami M. (1994) Total synthesis of a novel immunosuppressant, myriocin (thermozymocidin, ISP-I), and Z-myriocin. Chem Pharm Bull 42 : 994 996.
15. Adachi K., Kohara T., Nakao N., Arita M., Chiba K., Mishina T., Sasaki S., Fujita T. (1995) Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720. Bioorg Med Chem Lett 5 : 853 856.
16. Hirose R., Hamamichi N., Kitao Y., Matsuzaki T., Chiba K., Fujita T., (1996) 2-aminoalcohol immunosuppressants: Structure-activity relationships. Bioorg Med Chem Lett 6 : 2647 2650.